Prognostic factors and primary treatment for Waldenström macroglobulinemia – a Swedish Lymphoma Registry study

We present a nationwide prospective Swedish registry‐based study of Waldenström macroglobulinaemia (WM), that focuses on incidence and survival in relation to clinical prognostic factors and primary systemic therapies. A total of 1511 patients with WM and lymphoplasmocytic lymphoma (LPL) were regist...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of haematology Vol. 183; no. 4; pp. 564 - 577
Main Authors:	Brandefors, Lena, Melin, Beatrice, Lindh, Jack, Lundqvist, Kristina, Kimby, Eva
Format:	Journal Article
Language:	English
Published:	England Blackwell Publishing Ltd 01.11.2018
Subjects:	Diagnosis Hematology Hemoglobin Immunoglobulin M L-Lactate dehydrogenase Lactic acid ldenstrom macroglobulinaemia survival Lymphoma lymphoproliferative disease Macroglobulinemia Medical prognosis Medical records Monoclonal antibodies Patients prognostic factors Rituximab Survival Targeted cancer therapy therapy Waldenstrom macroglobulinaemia Waldenström macroglobulinaemia Waldenström macroglobulinaemia survival prognostic factors lymphoproliferative disease Waldenström macroglobulinaemia Waldenström macroglobulinaemia survival therapy
ISSN:	0007-1048, 1365-2141, 1365-2141
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!